This issue of the Emerging Cancer Therapeutics series provides a comprehensive review for Practitioners on the current status of Renal Cancer treatment. Renal Cancer treatment has undergone major changes over the course of the past few years and Renal Cancer addresses current best practises in the light of the most recent evidence. All of the chapters are written by international experts in the field, address the common clinical scenarios in Renal Cancer and are multidisciplinary in scope covering surgical, medical and radiation therapy. Chapters examining emerging and novel therapeutic targets, the management of both CNS and skeletal metastases in Renal Cancer round out the coverage.

Emerging Cancer Therapeutics features:

Editorial board of nationally recognised experts across the spectrum of Cancer therapeutics
In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer therapeutics
Issues edited by an authority in specific subject area
Focuses on major topics in Cancer therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
Emphasises multidisciplinary approaches to research and practice

Editor-in-chief: Jame Abraham